Back | Next |
home / stock / adxs / adxs message board
Subject | By | Source | When |
---|---|---|---|
I'm hearing a lot of chatter about psylocybin | Nickwvt | investorshub | 12/07/2022 4:49:27 PM |
Thanks man, much appreciated. Good luck and stay safe. | phytokaiser1 | investorshub | 12/05/2022 7:13:15 PM |
Dont give up, Phyto. Network, and talk to | ignatiusrielly35 | investorshub | 12/02/2022 8:35:32 PM |
Thanks and ya, it has been difficult but | phytokaiser1 | investorshub | 12/02/2022 7:46:28 PM |
Gee, Im not sure on that one, phyto. | ignatiusrielly35 | investorshub | 12/01/2022 5:42:13 PM |
Hey! It's good to talk to you again. I | phytokaiser1 | investorshub | 12/01/2022 5:23:10 PM |
If the data are good it will hit | ignatiusrielly35 | investorshub | 11/13/2022 3:45:19 AM |
Trick? or Treat? | hdwrsft | investorshub | 11/02/2022 3:16:49 PM |
And they'll offer $1.72 | Nickwvt | investorshub | 10/27/2022 12:04:33 AM |
Merger news....and the PPS goes wild.... Hmm. Maybe not | hdwrsft | investorshub | 10/20/2022 5:31:22 AM |
REHOVOT, Israel and WILMINGTON, Del. and MONMOUTH JUNCTION, | James salmon | investorshub | 10/19/2022 12:24:10 PM |
blue eye you have not posted on IHub | girlfriend | investorshub | 10/10/2022 7:23:23 PM |
Pretty soon Ken's salary will be more than | Nickwvt | investorshub | 09/29/2022 9:01:17 PM |
Lights are dimming...and have been for decades. | hdwrsft | investorshub | 09/28/2022 3:19:35 PM |
The lights will stay on on this company | Nickwvt | investorshub | 09/15/2022 4:30:29 PM |
Looks like this board is as dead as | ubmmg | investorshub | 09/14/2022 7:07:21 PM |
I'd sure hate to wake up in the | hdwrsft | investorshub | 08/02/2022 7:57:23 AM |
Redefining the obvious for the masses to consume | hdwrsft | investorshub | 07/30/2022 2:04:00 AM |
3rd quarter of 2023 the administration will gleefully | Nickwvt | investorshub | 07/29/2022 11:34:18 PM |
Recession or no recession... That is the question. | hdwrsft | investorshub | 07/26/2022 6:53:14 PM |
News, Short Squeeze, Breakout and More Instantly...
MONMOUTH JUNCTION, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced the completion of the previously announced sale of AL102, and related drug candidate AL101, to Immunome, Inc. (Nasdaq: IMNM). As per the ...
REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced that patient enrollment has been completed in the Phase 3 RINGSIDE study evaluating AL102 in desmoid tumors. A total of 156 ...
International Zeolite Corp. (IZCFF) is expected to report for Q2 2024 International Stem Cell Corporation (ISCO) is expected to report for Q4 2023 Zivo Bioscience Inc. (ZIVO) is expected to report for Q4 2023 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4...